Enulose and Unresponsive to stimuli - a phase IV clinical study of FDA data

Summary:

Unresponsive to stimuli is reported as a side effect among people who take Enulose (lactulose), especially for people who are female, 60+ old, also take Phoslo, and have Chronic renal failure.

The phase IV clinical study analyzes which people have Unresponsive to stimuli when taking Enulose. It is created by eHealthMe based on reports of 703 people who have side effects when taking Enulose from the FDA, and is updated regularly.

What is Enulose?

Enulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 711 Enulose users. Check the latest studies of Enulose.

What is Unresponsive to stimuli?

Unresponsive to stimuli is found to be associated with 1,339 drugs and 1,598 conditions by eHealthMe. Check the latest studies of Unresponsive to stimuli.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

703 people reported to have side effects when taking Enulose.
Among them, 15 people (2.13%) have Unresponsive to stimuli.

Could Enulose cause Unresponsive to stimuli?

Among these 15 people:

What is the gender of people who have Unresponsive to stimuli when taking Enulose? *

female: 53.33 %
male: 46.67 %

What is the age of people who have Unresponsive to stimuli when taking Enulose? *

What are other drugs people take besides Enulose? *

What are other side effects people have besides Unresponsive to stimuli? *

Hyperkalemia (damage to or disease of the kidney): 9 people, 60.00%
Diarrhea: 8 people, 53.33%
Abdominal Distension: 7 people, 46.67%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 7 people, 46.67%
Stress And Anxiety: 6 people, 40.00%
Pressure Ulcer: 5 people, 33.33%
Fatigue (feeling of tiredness): 5 people, 33.33%
Weakness: 5 people, 33.33%
High Blood Pressure: 5 people, 33.33%
Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 33.33%

What are the existing conditions these people have? *

Chronic Renal Failure (kidney failure): 3 people, 20.00%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 6.67%
Pain: 1 person, 6.67%
Heart Rate Irregular: 1 person, 6.67%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 1 person, 6.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.67%
Anaemia (lack of blood): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Enulose and have Unresponsive to stimuli?

- Check whether Unresponsive to stimuli is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Enulose:

Enulose (711 reports)

Browse all side effects of Enulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Unresponsive to stimuli:

Unresponsive to stimuli (1,339 drugs)

Browse all the conditions that are associated with Unresponsive to stimuli:

Unresponsive to stimuli (1,598 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lactulose (the active ingredients of Enulose) and Enulose (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.